Literature DB >> 7753546

Cell type-specific trans-activation by the B-myb gene product: requirement of the putative cofactor binding to the C-terminal conserved domain.

S Tashiro1, Y Takemoto, H Handa, S Ishii.   

Abstract

The myb gene family has three members, c-myb, A-myb and B-myb. We have examined the trans-activating capacity of the B-myb gene product (B-Myb) in various types of cells. B-Myb functions as a transcriptional activator in CV-1 and HeLa cells, but not in NIH3T3 cells, indicating that B-Myb is a cell type-specific transcriptional activator. Deletion analyses of B-Myb have demonstrated that the region conserved between three members of the myb gene family (CR for conserved region) is necessary for trans-activation by B-Myb. An in vivo competition assay suggests that regulatory factor(s) that binds to the CR of B-Myb is required for transactivation. Analyses using an affinity resin show that multiple proteins bind to the CR of B-Myb and that the CR-binding proteins in CV-1 and HeLa cells are different from those in NIH3T3 cells. These results suggest that the CR-binding cofactor(s) is critical for the cell type-specific trans-activation by B-Myb.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7753546

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  5 in total

1.  An inhibitor domain in Sp3 regulates its glutamine-rich activation domains.

Authors:  J Dennig; M Beato; G Suske
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

2.  Phenotypic and morphological characterization of neuroblastoma cells constitutively expressing B-myb.

Authors:  S Scarpa; A Negroni; R Amendola; P Signorelli; B Calabretta; A Modesti; G Raschellà
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

3.  Activation of human B-MYB by cyclins.

Authors:  A Sala; M Kundu; I Casella; A Engelhard; B Calabretta; L Grasso; M G Paggi; A Giordano; R J Watson; K Khalili; C Peschle
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

4.  The C-terminal domain of B-Myb acts as a positive regulator of transcription and modulates its biological functions.

Authors:  I H Oh; E P Reddy
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

5.  B-Myb acts as a repressor of human COL1A1 collagen gene expression by interacting with Sp1 and CBF factors in scleroderma fibroblasts.

Authors:  Lucia Cicchillitti; Sergio A Jimenez; Arturo Sala; Biagio Saitta
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.